Skip Navigation LinksHome > July 2014 - Volume 33 - Issue 7 > Clinical Evaluation of Vancomycin Dosage in Pediatric Oncolo...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000268
Antimicrobial Reports

Clinical Evaluation of Vancomycin Dosage in Pediatric Oncology Patients

Sanders, Stefan J.W.J. PharmD*; Bijleveld, Yuma A. PharmD*; Sinkeler, Fleur BSc*; Kemper, Elles M. PharmD, PhD*; Pajkrt, Dasja MD, PhD, MBA; van de Wetering, Marianne MD, PhD; van Eijkelenburg, Natasha K.A. MD; Mathôt, Ron A.A. PharmD, PhD*

Collapse Box


Vancomycin trough serum concentrations were below therapeutic range (8–15 mg/L) in 58% of 124 pediatric oncology patients receiving 60 mg/kg/d divided qid. Patients <6 and between 6 and 12 years had significantly lower trough concentrations than patients >12 years. A vancomycin dosage of 60 mg/kg/d is inadequate for pediatric oncology patients >12 years.

© 2014 by Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.